NVAX vs. AMGN

In the year-to-date period, NVAX achieves a -21.77% return, which is significantly lower than AMGN's 5.08% return. Over the past 10 years, NVAX has underperformed AMGN with an annualized return of -28.33%, while AMGN has yielded a comparatively higher 8.25% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Novavax, Inc. (NVAX) and Amgen Inc. (AMGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current NVAX Sharpe Ratio is -0.55, which is comparable to the AMGN Sharpe Ratio of -0.46. The chart below compares the historical Sharpe Ratios of NVAX and AMGN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

NVAX has not paid dividends to shareholders, while AMGN's dividend yield for the trailing twelve months is around 4.24%.

The maximum NVAX drawdown since its inception was -98.82%, which is greater than AMGN's maximum drawdown of -78.02%. Use the drawdown chart below to compare losses from any high point for NVAX and AMGN. For additional features, visit the drawdowns tool.

Novavax, Inc. (NVAX) has a higher volatility of 29.26% compared to Amgen Inc. (AMGN) at 9.10%. This indicates that NVAX's price experiences larger fluctuations and is considered to be riskier than AMGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Novavax, Inc. and Amgen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.